These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Genetic counseling for BRCA1/BRCA2 testing. Schneider KA Genet Test; 1997; 1(2):91-8. PubMed ID: 10464632 [TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414del4 found in male breast cancer. Balci A; Huusko P; Pääkkönen K; Launonen V; Uner A; Ekmekçi A; Winqvist R Eur J Cancer; 1999 May; 35(5):707-10. PubMed ID: 10505028 [TBL] [Abstract][Full Text] [Related]
27. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families. Vaziri SA; Krumroy LM; Rostai M; Casey G Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249 [TBL] [Abstract][Full Text] [Related]
28. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874 [TBL] [Abstract][Full Text] [Related]
29. Coming to grips with genes and risk. Kahn P Science; 1996 Oct; 274(5287):496-8. PubMed ID: 8928001 [No Abstract] [Full Text] [Related]
32. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland. Ikonen T; Matikainen MP; Syrjäkoski K; Mononen N; Koivisto PA; Rökman A; Seppälä EH; Kallioniemi OP; Tammela TL; Schleutker J J Med Genet; 2003 Aug; 40(8):e98. PubMed ID: 12920090 [No Abstract] [Full Text] [Related]
33. Hereditary breast cancer: high risk genes, genetic testing and clinical implications. Hamann U Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530 [TBL] [Abstract][Full Text] [Related]
34. Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. Ozdag H; Tez M; Sayek I; Müslümanoglu M; Tarcan O; Içli F; Oztürk M; Ozçelik T Eur J Cancer; 2000 Oct; 36(16):2076-82. PubMed ID: 11044644 [TBL] [Abstract][Full Text] [Related]
35. [From gene to disease; from BRCA1 or BRCA2 to breast cancer]. Devilee P; Tollenaar RA; Cornelisse CJ Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2549-51. PubMed ID: 11191790 [TBL] [Abstract][Full Text] [Related]
36. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595 [TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy. Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599 [TBL] [Abstract][Full Text] [Related]
38. [Generic screening for breast cancer]. Ponti A; Giordano L Epidemiol Prev; 1999; 23(4):369-71. PubMed ID: 10730478 [TBL] [Abstract][Full Text] [Related]
39. A rapid immunoassay predicts BRCA1 and BRCA2 mutations in buccal cells. Byrne TJ; Reece MT; Adams LA; Hoffman DE; Lane MA; Cohn GM Oncol Rep; 2000; 7(6):1203-7. PubMed ID: 11032914 [TBL] [Abstract][Full Text] [Related]
40. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]